Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan M Fogelman

Showing results (61-70 of 149) with videos related to

Pageof 15
Sort By:
Prostaglandins & Other Lipid Mediators|July 24, 2007
A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitorsAjay Narasimha, Junji Watanabe, James A Lin, et al.
Current Opinion in Lipidology|November 6, 2004
Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversalMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Journal of Lipid Research|August 19, 2007
Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbitsBrian J Van Lenten, Alan C Wagner, Mohamad Navab, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 19, 2012
High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literatureMohamad Navab, Srinivasa T Reddy, Brian J Van Lenten, et al.
Journal of the National Medical Association|August 12, 2011
Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal diseaseNosratola D Vaziri, Kaveh Navab, Pavan Gollapudi, et al.
Current Atherosclerosis Reports|December 17, 2008
Apolipoprotein A-I mimetic peptidesBrian J Van Lenten, Alan C Wagner, G M Anantharamaiah, et al.
Clinical and Translational Science|August 11, 2017
Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled TrialRichard L Dunbar, Rajesh Movva, LeAnne T Bloedon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 21, 2007
Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient miceCarey J Ng, Noam Bourquard, Susan Y Hama, et al.
Vascular Pharmacology|November 27, 2002
Identification of genes induced by oxidized phospholipids in human aortic endothelial cellsSrinivasa T Reddy, Victor Grijalva, Carey Ng, et al.
The American Journal of Cardiology|September 21, 2013
Heart failure is associated with impaired anti-inflammatory and antioxidant properties of high-density lipoproteinsJuyong Brian Kim, Susan Hama, Greg Hough, et al.
Pageof 15

Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
Prostaglandins & Other Lipid Mediators|July 24, 2007
A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitorsAjay Narasimha, Junji Watanabe, James A Lin, et al.
Current Opinion in Lipidology|November 6, 2004
Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversalMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Journal of Lipid Research|August 19, 2007
Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbitsBrian J Van Lenten, Alan C Wagner, Mohamad Navab, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 19, 2012
High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literatureMohamad Navab, Srinivasa T Reddy, Brian J Van Lenten, et al.
Journal of the National Medical Association|August 12, 2011
Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal diseaseNosratola D Vaziri, Kaveh Navab, Pavan Gollapudi, et al.
Current Atherosclerosis Reports|December 17, 2008
Apolipoprotein A-I mimetic peptidesBrian J Van Lenten, Alan C Wagner, G M Anantharamaiah, et al.
Clinical and Translational Science|August 11, 2017
Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled TrialRichard L Dunbar, Rajesh Movva, LeAnne T Bloedon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 21, 2007
Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient miceCarey J Ng, Noam Bourquard, Susan Y Hama, et al.
Vascular Pharmacology|November 27, 2002
Identification of genes induced by oxidized phospholipids in human aortic endothelial cellsSrinivasa T Reddy, Victor Grijalva, Carey Ng, et al.
The American Journal of Cardiology|September 21, 2013
Heart failure is associated with impaired anti-inflammatory and antioxidant properties of high-density lipoproteinsJuyong Brian Kim, Susan Hama, Greg Hough, et al.
Pageof 15